http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-494326-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e70c0aeade92d7571d955d3b90ea06e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B1-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09B1-40
filingDate 1937-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1938-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-494326-A
titleOfInvention Anthraquinone derivatives and their manufacture
abstract Nitroformylaminoanthraquinones are made by nitration of formylaminoanthraquinones. The products may be reduced to aminoformylaminoanthraquinones and then hydrolysed to polyaminoanthraquinones, or hydrolysed to nitroaminoanthraquinones followed by reduction. The reduction and hydrolysis may also be carried out simultaneously. When two formylamino groups are present the anthraquinone can be mono- or di-nitrated, according to the amount of nitrating agent. In examples: (1) 1.5-diformylaminoanthraquinone is dinitrated to 1,5-diformylamino4.8 - dinitroanthraquinone, which may be hydrolysed to 1.5-diamino-4.8-dinitroanthraquinone with sulphuric acid or caustic soda, followed by reduction to 1.4.5.8-tetraaminoanthraquinone, or reduced to 1.5-diformlyamino-4.8-diaminoanthraquinone, followed by hydrolysis with sulphuric acid; (2) 1,5-diformylaminoanthraquinone is mononitrated to 1.5 - diformylamino - 4 - nitroanthraquinone, hydrolysed and reduced, or reduced to 1.5-diformylamino - 4 - aminoanthraquinone; (3) 1.8 - diformylaminoanthraquinone is mononitrated to 1.8-diformylamino - 4 - nitroanthraquinone, which may be reduced, or hydrolysed and reduced; (4) 1-formylaminoanthraquinone is mononitrated to 1-formylamino - 4 - nitroanthraquinone, which may be hydrolysed or reduced, or hydrolysed and reduced simultaneously; (5) 1.5-diformylamino - 4.8 - dinitroanthraquinone is reduced and hydrolysed simultaneously. Formylaminoanthraquinones may be obtained from aminoanthraquinones and formic acid or from halogenanthraquinones and formamide, according to Specification 494,320.
priorityDate 1936-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430744892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457569339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21522838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413371279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85570374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431971396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89953622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153800273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410445160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429279475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154113040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431305511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420129856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13593656

Total number of triples: 34.